Immunoprecise Stock Market Sentiment

IPA
 Stock
  

USD 3.84  0.11  2.78%   

Immunoprecise investor sentiment overview provides quick insight into current market opportunities from investing in Immunoprecise Antibodies. The current market sentiment together Immunoprecise Antibodies' historical and current headlines can help investors to time the market. Many technical investors use Immunoprecise Antibodies stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Please see Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Correlation and Immunoprecise Antibodies Performance.
  
Refresh
Immunoprecise Antibodies stock news, alerts, and headlines are usually related to their technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Immunoprecise daily returns and investor perception about the current pice of Immunoprecise Antibodies as well as its diversification or hedging effects on your existing portfolios.

Immunoprecise Latest Sentiment Indicators

200 Day MA
5.43
Short Percent
0.0258
Short Ratio
14.43
Shares Short Prior Month
240.8 K
50 Day MA
4.87
52 Week Low
3.51
Shares Short
231.7 K
over three months ago at www.marketscreener.com         
ImmunoPrecise Antibodies Immunotherapeutic PolyTope from ImmunoPrecise Potently Neutralizes the SARS...
news
over three months ago at www.marketscreener.com         
Immunotherapeutic PolyTope from ImmunoPrecise Potently Neutralizes the SARS-CoV-2 Omicron Variant Mo...
news
over three months ago at www.bakersfield.com         
ImmunoPrecise Antibodies Announces Grant of Stock Options News bakersfield.com - The Bakersfield Cal...
news
over three months ago at www.bakersfield.com         
ImmunoPrecise Antibodies Announces Grant of Stock Options News bakersfield.com - The Bakersfield Cal...
news
over six months ago at www.valdostadailytimes.com         
ImmunoPrecise Antibodies Announces Grant of Stock Options Business valdostadailytimes.com - Valdosta...
news
over six months ago at www.marketscreener.com         
ImmunoPrecise Antibodies and ChemPartner Biologics Announce PolyTope TATX-03 Antibody Cocktail Manuf...
news
over six months ago at www.marketscreener.com         
ImmunoPrecise Antibodies MANAGEMENT DISCUSSION AND ANALYSIS FOR THE SIX MONTHS ENDED OCTOBER 31, 202...
news
over six months ago at www.galvnews.com         
ImmunoPrecise Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Yea...
news
over six months ago at finance.yahoo.com         
ImmunoPrecise Update on its SARS-CoV-2 PolyTope Multi-Antibody Cocktail Development Program - Yahoo ...
Yahoo News
over six months ago at www.marketscreener.com         
ImmunoPrecise Antibodies Update on its SARS-CoV-2 PolyTope Multi-Antibody Cocktail Development Progr...
news
over six months ago at Macroaxis         
Will Immunoprecise Antibodies (NASDAQ:IPA) investors shift to Mustang (NASDAQ:MBIO)?
Macroaxis News
over six months ago at finance.yahoo.com         
ImmunoPrecise to Present at the Benchmark Companys Discovery One-on-One Virtual Video Investor Confe...
Yahoo News
over six months ago at simplywall.st         
While shareholders of ImmunoPrecise Antibodies are in the black over 3 years, those who bought a wee...
Simply Wall St News at Macroaxis
over six months ago at finance.yahoo.com         
Research Antibodies Market Size Is Projected to Reach 6.35 Billion by 2028 CAGR 6.5 percent Polaris ...
Yahoo News
over six months ago at www.equities.com         
ImmunoPrecise Antibodies falls 2.37 percent on Moderate Volume November 2 - Equities.com
Equities News
There is far too much social signal, news, headlines, and media speculation about Immunoprecise Antibodies that is available to investors today. That information is available publicly through Immunoprecise media outlets and privately through word of mouth or via Immunoprecise internal channels. However, regardless of the origin, that massive amount of Immunoprecise data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Immunoprecise Antibodies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Immunoprecise Antibodies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Immunoprecise Antibodies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Immunoprecise Antibodies alpha.

Immunoprecise Antibodies Performance against DOW

 Price Growth (%)  
      Timeline 
1
Other04/12/2022
2
IPA Completes Acquisition of Belgian Technology Companies Bi...04/13/2022
3
Other04/14/2022
4
Other04/20/2022
5
ImmunoPrecise Antibodies Form 51-102F3 MATERIAL CHANGE REPOR...04/25/2022
6
IPAs Subsidiary BioStrand Secures Second VLAIO Research Gran...05/09/2022
Please see Immunoprecise Antibodies Hype Analysis, Immunoprecise Antibodies Correlation and Immunoprecise Antibodies Performance. Note that the Immunoprecise Antibodies information on this page should be used as a complementary analysis to other Immunoprecise Antibodies' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Positions Ratings module to determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Immunoprecise Stock analysis

When running Immunoprecise Antibodies price analysis, check to measure Immunoprecise Antibodies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunoprecise Antibodies is operating at the current time. Most of Immunoprecise Antibodies' value examination focuses on studying past and present price action to predict the probability of Immunoprecise Antibodies' future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Immunoprecise Antibodies' price. Additionally, you may evaluate how the addition of Immunoprecise Antibodies to your portfolios can decrease your overall portfolio volatility.
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Go
Fundamental Analysis
View fundamental data based on most recent published financial statements
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
Is Immunoprecise Antibodies' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunoprecise Antibodies. If investors know Immunoprecise will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Immunoprecise Antibodies listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Market Capitalization
96.9 M
Quarterly Revenue Growth YOY
0.066
Return On Assets
-0.19
Return On Equity
-0.43
The market value of Immunoprecise Antibodies is measured differently than its book value, which is the value of Immunoprecise that is recorded on the company's balance sheet. Investors also form their own opinion of Immunoprecise Antibodies' value that differs from its market value or its book value, called intrinsic value, which is Immunoprecise Antibodies' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Immunoprecise Antibodies' market value can be influenced by many factors that don't directly affect Immunoprecise Antibodies' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Immunoprecise Antibodies' value and its price as these two are different measures arrived at by different means. Investors typically determine Immunoprecise Antibodies value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunoprecise Antibodies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.